Novel N-indolylmethyl substituted olanzapine derivatives: their design, synthesis and evaluation as PDE4B inhibitors

被引:34
作者
Gorja, Dhilli Rao [1 ,2 ]
Mukherjee, Soumita [1 ]
Meda, Chandana Lakshmi T. [1 ]
Deora, Girdhar Singh [1 ]
Kumar, K. Lalith [1 ]
Jain, Ankit [1 ,3 ]
Chaudhari, Girish H. [1 ,3 ]
Chennubhotla, Keerthana S. [1 ,3 ]
Banote, Rakesh K. [1 ,3 ]
Kulkarni, Pushkar [1 ,3 ]
Parsa, Kishore V. L. [1 ]
Mukkanti, K. [2 ]
Pal, Manojit [1 ]
机构
[1] Inst Life Sci, Hyderabad 500046, Andhra Pradesh, India
[2] JNT Univ, Inst Sci & Technol, Div Chem, Hyderabad 500072, Andhra Pradesh, India
[3] Zephase Therapeut Pvt Ltd, Hyderabad 500046, Andhra Pradesh, India
关键词
ADVANCED CANCER; PHOSPHODIESTERASE-4; SELECTIVITY; DISCOVERY; NAUSEA;
D O I
10.1039/c3ob27424a
中图分类号
O62 [有机化学];
学科分类号
070303 ; 081704 ;
摘要
A new strategy for converting antipsychotic drug olanzapine into PDE4 inhibitors is described via the design and Pd/C mediated synthesis of novel N-indolylmethyl olanzapine derivatives. One compound showed good inhibition (IC50 1.1 mu M) and >10 fold selectivity towards PDE4B over D that was supported by docking studies. This compound also showed significant inhibition of TNF-alpha and no major toxicities in cell lines and a zebrafish embryo model except the teratogenic effects to be re-assessed in rodents.
引用
收藏
页码:2075 / 2079
页数:5
相关论文
共 30 条
[1]   Novel thieno[2,3-d]pyrimidines: their design, synthesis, crystal structure analysis and pharmacological evaluation [J].
Adepu, Raju ;
Rambabu, D. ;
Prasad, Bagineni ;
Meda, Chandana Lakshmi T. ;
Kandale, Ajit ;
Krishna, G. Rama ;
Reddy, C. Malla ;
Chennuru, Lakshmi N. ;
Parsa, Kishore V. L. ;
Pal, Manojit .
ORGANIC & BIOMOLECULAR CHEMISTRY, 2012, 10 (29) :5554-5569
[2]   Improving memory: A role for phosphodiesterases [J].
Blokland, A. ;
Schreiber, R. ;
Prickaerts, J. .
CURRENT PHARMACEUTICAL DESIGN, 2006, 12 (20) :2511-2523
[3]  
Briggs G., 2008, DRUGS PREGNANCY LACT, P1355
[4]   Novel atypical antipsychotic agents: Rational design, an efficient palladium-catalyzed route, and pharmacological studies [J].
Campiani, G ;
Butini, S ;
Fattorusso, C ;
Trotta, F ;
Gemma, S ;
Catalanotti, B ;
Nacci, V ;
Fiorini, I ;
Cagnotto, A ;
Mereghetti, I ;
Mennini, T ;
Minetti, P ;
Di Cesare, MA ;
Stasi, MA ;
Di Serio, S ;
Ghirardi, O ;
Tinti, O ;
Carminati, P .
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (06) :1705-1708
[5]   Pharmacology of a potent and selective inhibitor of PDE4 for inhaled administration [J].
Chapman, Richard W. ;
House, Aileen ;
Richard, Jennifer ;
Prelusky, Dan ;
Lamca, James ;
Wang, Peng ;
Lundell, Dan ;
Wu, Ping ;
Ting, Pauline C. ;
Lee, Joe F. ;
Aslanian, Robert ;
Phillips, Jonathan E. .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2010, 643 (2-3) :274-281
[6]   Identification of pyridazino[4,5-b]indolizines as selective PDE4B inhibitors [J].
Donnell, Andrew F. ;
Dollings, Paul J. ;
Butera, John A. ;
Dietrich, Arlene J. ;
Lipinski, Kerri K. ;
Ghavami, Afshin ;
Hirst, Warren D. .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (07) :2163-2167
[7]   Strain-dependent neurochemical and neuroendocrine effects of desipramine, but not fluoxetine or imipramine, in Spontaneously Hypertensive and Wistar-Kyoto rats [J].
Durand, M ;
Aguerre, S ;
Fernandez, F ;
Edno, L ;
Combourieu, I ;
Mormède, P ;
Chaouloff, F .
NEUROPHARMACOLOGY, 2000, 39 (12) :2464-2477
[8]  
Fairhurst J., 2000, US Patent Application, Patent No. [US006034078A, 006034078]
[9]   Phosphodiesterase-4 as a therapeutic target [J].
Houslay, MD ;
Schafer, P ;
Zhang, KYJ .
DRUG DISCOVERY TODAY, 2005, 10 (22) :1503-1519
[10]   The synthesis and biological evaluation of a novel series of indole PDE4 inhibitors I [J].
Hulme, C ;
Moriarty, K ;
Miller, B ;
Mathew, R ;
Ramanjulu, M ;
Cox, P ;
Souness, J ;
Page, KM ;
Uhl, J ;
Travis, J ;
Huang, FC ;
Labaudiniere, R ;
Djuric, SW .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1998, 8 (14) :1867-1872